您现在位置： -医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Alprostadil Market Report

讯：

Research Report On Chinese Alprostadil Market(2007 Edition)

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  April 2007
Format:  Hardcopy and Adobe PDF
Price:  US$ 16,00
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68052505
E-mail: bianch@healthoo.com   wuhf@healthoo.com                     
//m.limatoxi.com

Table of contents
1 Brief introduce of Alprostadil
  1.1 Development history
  1.2 introduce of clinical uses
  1.3 Production situation of Alprostadil in China
2 Market analysis of Alprostadil
  2.1 Growth trend of Alprostadil from 2002 to 2006
  2.2 Sales values of Alprostadil for different enterprises (brands) from 2002 to 2006
  2.3 Sales shares of Alprostadil for different enterprises (brands) from 2002 to 2006
    2.3.1 Sales shares of different brands
      Beijing
      Shhanghai
      Guangzhou
      Hangzhou
      Nanjing
    2.3.2 Slaes shares of “KaiShi” in different cities from 2002 to 2006
    2.3.3 Slaes shares of “BaoSaXin” in different cities from 2002 to 2006
    2.3.4 Slaes shares of “BoLeSi” in different cities from 2002 to 2006
    2.3.5 Slaes shares of “SaiEr” in different cities from 2002 to 2006
    2.3.6 Slaes shares of “KangPuXi” in different cities from 2002 to 2006
3 Aanlysis on the foumulaions, specifacations and prices
4 Market forcast

Tables and figures
Table 1 List of domestic marketed products and import procucts
Table 2 List of enterprises which are applying the registertion of Sulpiride
Table 3 Sales values in sample hospitals from 2002 to 2006
Table 4 Sales rank of Alprostadil manufacturers in sample hospitals in 2006
Table 5 Sales values of different brands from 2002 to 2006
Table 6 Sales values of Alprostadil in key cities from 2002 to 2006
Table 7 Sales values and shares of “KaiShi” in key cities from 2002 to 2006
Table 8 Sales values and shares of “BaoSaXin” in key cities from 2002 to 2006
Table 9 Sales values and shares of “BoLeSi” in key cities from 2002 to 2006
Table 10 Sales values and shares of “SaiEr” in key cities from 2002 to 2006
Table 11 Sales values and shares of “KangPuXi” in key cities from 2002 to 2006
Table 11 Retail prices

Figure 1 Growth trend from 2002 to 2006
Figure 2 Market shares of different enterprises in 2006
Figure 3 Market shares of different enterprises in 2005
Figure 4 Sales trends of top 5 brands from 2002 to 2006
Figure 5 Sales trends of different brands in Beijing from 2002 to 2006
Figure 6 Sales trends of different brands in Shanghai from 2002 to 2006
Figure 7 Sales trends of different brands in Guangzhou from 2002 to 2006
Figure 8 Sales trends of different brands in Hangzhou from 2002 to 2006
Figure 9 Sales trends of different brands in Nanjing from 2002 to 2006
Figure 10 Sales trend of “KaiShi” from 2002 to 2006
Figure 11 Sales trends of “KaiShi” in 5 cities from 2002 to 2006
Figure 12 Average gorwth of “KaiShi” from 2002 to 2006
Figure 13 Sales trend of “BaoSaXin” from 2002 to 2006
Figure 14 Sales trends of “BaoSaXin” in 5 cities from 2002 to 2006
Figure 15 Average gorwth of “BaoSaXin” from 2002 to 2006
Figure 16 Sales trend of “BoLeSi” from 2002 to 2006
Figure 17 Sales trends of “BoLeSi” in 5 cities from 2002 to 2006
Figure 18 Average gorwth of “BoLeSi” from 2002 to 2006
Figure 19 Sales trend of “SaiEr” from 2002 to 2006
Figure 20 Sales trends of “SaiEr” in 5 cities from 2002 to 2006
Figure 21 Average gorwth of “SaiEr” from 2002 to 2006
Figure 22 Sales trend of  from 2002 to 2006
Figure 23 Sales amounts of Alprostadil with different formulations from 2002 to 2006
Figure 24 Sales values of Alprostadil with different formulations from 2002 to 2006
Figure 25 Sales values of powder for injection with different specifications from 2002 to 2006
Figure 26 Sales amounts of powder for injection with different specifications from 2002 to 2006
Figure 27 Sales values of liposome formulation with different specifications from 2002 to 2006
Figure 28 Sales amounts of liposome formulation with different specifications from 2002 to 2006